Overview

A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.

Status:
Completed
Trial end date:
2016-09-09
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of a new eye drop formulation in patients with dry eye disease.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
Carboxymethylcellulose Sodium
Ophthalmic Solutions
Tetrahydrozoline